C.R. Bard Acquires NeoMend for $165,000,000
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cdeb8658-f901-4f6e-97ad-b8c5efd80945&Preview=1 -
Date
10/24/2012 -
Company Name
NeoMend -
Mailing Address
60 Technology Drive Irvine, CA 92618 -
Company Description
NeoMend, Inc. is a privately held, clinical stage biomedical device company engaged in the development and commercialization of advanced surgical wound healing products. -
Website
http://www.neomend.com -
Transaction Type
M&A -
Transaction Amount
$165,000,000 -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
The merger consideration is for a purchase price of $140 million paid at closing and future contingent payments up to an additional $25 million based on specific revenue-based milestones through 2016.
